查詢結果分析
相關文獻
- Effects of Fluconazole Prophylaxis Against Systemic Fungal Infection in Extremely-low-birth-weight Infants
- Comparison of the Outcome of Extremely-Low-Birth-Weight Infants between Two Periods
- 極低體重兒使用中鍵/長鍵三酸甘油脂靜脈營養的效果評估
- Early Outcome of Extremely Low Birth Weight Infants in Taiwan
- A Survey on the Treatment Strategy of Patent Ductus Arteriosus in Very Low-Birth-Weight Infants
- Glutamine Supplementation for Low-Birth-Weight and Very Low-Birth-Weight Infants
- Rigid Bronchoscopy and Jet Ventilation in an Extremely Low Birthweight Infant
- 間隔性方法對極低體重兒鈣質代謝的分析
- 新生兒的全身性黴菌感染
- Symptomatic Patent Ductus Arteriosus in Very Low Birth Weight Infants
第1筆 /總和 1 筆
/ 1 筆
頁籤選單縮合
題名 | Effects of Fluconazole Prophylaxis Against Systemic Fungal Infection in Extremely-low-birth-weight Infants=投予預防性Fluconazole對降低極低體重兒全身性黴菌感染成效評估 |
---|---|
作者 | 蔡政憲; 鄭靜蘭; 林毓志; 劉清泉; 高雅慧; 林其和; Tsai, Cheng-hsien; Cheng, Ching-lan; Lin, Yuh-jyh; Liu, Ching-chuan; Kao Yang, Yea-huei; Lin, Chyi-her; |
期刊 | Clinical Neonatology |
出版日期 | 20060600 |
卷期 | 12:1 民94.06 |
頁次 | 頁6-12 |
分類號 | 417.517 |
語文 | eng |
關鍵詞 | 極低體重兒; 全身性黴菌感染; Fluconazole; Chemoprophylaxis; Extremely-low-birth-weight; Fungemia; |
英文摘要 | Background: Prophylactic administration of fluconazole has been demonstrated to be effective in reducing systemic fungal infection in extremely-low-birth-weight (ELBW) infants. This study investigated the effects and side effects of this regimen in a tertiary care center Methods: ELBW infants younger than 5 days old admited to the Neonatal Intensive Care Unit of a university hospital between May 2000 and April 2004 were enrolled. Period A, May 2000 to April 2002, was used as the baseline. Period B, May 2002 to April 2004, was the period of fluconazole prophylaxis. Fluconazole (3 mg/kg) was administered intravenously every 72 h in the first 2 wks of life, every 48 h at 3-4 wks, and every 24 h at 5-6 wks. Laboratory parameters were recorded weekly for 7 weeks. Patient data, including predisposing factors, incidence of systemic infections, and blood chemistry tests in ELBW infants were compared between Period A and B. Results: There were 49 ELBW infants in period A and 57 infants in period B. The mean gestational age, birth weight, antenatal interventions, and delivery modes of the infants were similar in both groups. There were no significant differences in the distribution of risk factors between periods. However nine patients (18.4%) developed fungemia during period A, and 4 patients (7.0%) during period B. Only two (3.5%) contracted fungemia during chemoprophylaxis. The incidence of fungemia was lower in period B (0.65 per 1000 patient-days) than in period A (3.54 per 1000 patient-days). (95% C.I. -5.37 to -0.41 per 1000 patient-days, p=0.01). The age at onset of fungemia (36.3±8.7 days) in period B was significantly older than in period A (20.6±4.1 days, p=0.04). There was no fungemia-related mortality in period B. In contrast, 5 patients (55%) with fungemia died, and 2 (22%) had fungus-related mortality in period A. Conclusions: Early prophylaxis with fluconazole in ELBW infants decreased the incidence of fungemia without increasing adverse events. Whether a prolonged duration of medication would provide better coverage requires further study. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。